FGF23 and chronic kidney disease: Symptoms of SHPT are caused by altered bone metabolism, in which elevated PTH and FGF23 levels, low/normal calcemia, and low 1α,25-(OH)2D variably contribute to the bone alterations defining the chronic kidney disease-mineral bone disease (CKD-MBD).